Skip to Main Content

INFORMATION FOR

    Boby Mathew

    Associate Research Scientist

    About

    Titles

    Associate Research Scientist

    Appointments

    Other Departments & Organizations

    Research

    Research at a Glance

    Yale Co-Authors

    Frequent collaborators of Boby Mathew's published research.

    Publications

    2026

    • Beta cell-derived cholecystokinin drives obesity-associated pancreatic adenocarcinoma development
      Garcia CC, Venkat A, McQuaid DC, Agabiti SS, Tong A, Mathew B, Cardone RL, Starble R, Ruiz CF, Zheng C, Sogunro A, Jacox JB, Loh KH, Kibbey RG, Krishnaswamy S, Muzumdar MD. Beta cell-derived cholecystokinin drives obesity-associated pancreatic adenocarcinoma development. Nature Communications 2026 DOI: 10.1038/s41467-026-69821-2.
      Peer-Reviewed Original Research
      This study investigates how beta cell-derived cholecystokinin drives obesity-associated pancreatic cancer development, showing that targeting endocrine signaling could prevent tumor progression in obesity-related contexts.
    • Beta cell-derived cholecystokinin drives obesity-associated pancreatic adenocarcinoma development
      Garcia C, Venkat A, McQuaid D, Agabiti S, Tong A, Mathew B, Cardone R, Starble R, Ruiz C, Zheng C, Sogunro A, Jacox J, Loh K, Kibbey R, Krishnaswamy S, Muzumdar M. Beta cell-derived cholecystokinin drives obesity-associated pancreatic adenocarcinoma development. Nature Communications 2026, 17: 3292. PMID: 41760660, PMCID: PMC13066563, DOI: 10.1038/s41467-026-69821-2.
      Peer-Reviewed Original Research
      This study investigates how obesity-induced cholecystokinin (CCK) expression in pancreatic beta cells drives pancreatic cancer development by altering cellular signaling within the environment of arising tumors, suggesting potential therapeutic targets.

    2022

    2021

    Get In Touch